XML 44 R29.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2019
Income Tax Disclosure [Abstract]  
Schedule of Income before Income Tax, Domestic and Foreign
The following are the domestic and foreign components of the Company’s income before income taxes (in thousands):
 
Year Ended  
December 31,
 
2019
 
2018
 
2017
Domestic
$
14,544

 
$
36,157

 
$
(16,583
)
Foreign
66,102

 
18,921

 
48,848

Income before income taxes
$
80,646

 
$
55,078

 
$
32,265


Income Tax Benefit
The income tax benefit is comprised of the following (in thousands):
 
Year Ended  
December 31,
 
2019
 
2018
 
2017
Current:
 
 
 
 
 
Federal
$
(3,967
)
 
$
709

 
$
(6,397
)
State
1,053

 
(578
)
 
79

Foreign
352

 
600

 
476

Total current
(2,562
)
 
731

 
(5,842
)
Deferred:
 
 
 
 
 
Federal
(19,734
)
 
(3,343
)
 
(34,948
)
State
(1,564
)
 
3,496

 
(8,778
)
Foreign
8,612

 
(23,297
)
 
33

Total deferred
(12,686
)
 
(23,144
)
 
(43,693
)
Total income tax benefit
$
(15,248
)
 
$
(22,413
)
 
$
(49,535
)

Reconciliation of the Income Tax Benefit
A reconciliation of the income tax benefit at the U.S. federal statutory income tax rate to the Company’s total income tax benefit is as follows (in thousands):
 
Year Ended  
December 31,
 
2019
 
2018
 
2017
Income tax provision at the federal statutory rate (a)
$
16,936

 
$
11,566

 
$
11,308

State and local income taxes net of federal benefit
973

 
3,839

 
(691
)
Foreign income tax rate differential
(5,454
)
 
(298
)
 
(11,878
)
Stock-based compensation
(16,281
)
 
(11,717
)
 
(12,584
)
Research and development credit
(9,864
)
 
(4,115
)
 
(1,098
)
U.S. tax reform (b)
(4,197
)
 
3,897

 
(31,063
)
Non-deductible expenses
1,784

 
(329
)
 
168

Uncertain tax positions
380

 
382

 
789

Change in valuation allowance (c)

 
(28,733
)
 
(4,673
)
Return to provision adjustment
500

 
3,293

 
167

Other
(25
)
 
(198
)
 
20

Total income tax benefit
$
(15,248
)
 
$
(22,413
)
 
$
(49,535
)


(a) The income tax provision at the U.S. federal statutory rate is computed using 21% in 2019 and 2018 and 35% in 2017. Refer to footnote (b) below.

(b) On December 22, 2017, the U.S. government enacted the TCJA, as described above, which includes significant changes to the taxation of business entities. These changes include, among others, (1) a permanent reduction to the corporate income tax rate, (2) Global Intangible Low-Taxed Income (“GILTI”), a new tax on worldwide income, and (3) Foreign Derived Intangible Income (“FDII”) a deduction provided with respect to certain foreign earned income. Effective January 1, 2018, the Company is subject to several provisions of the TCJA including computations under GILTI and FDII.

For the year ended December 31, 2017, primarily as a result of the permanent change in U.S. corporate income tax rate, the Company recognized a net income tax benefit of $31.1 million associated with the TCJA.

For the years ended December 31, 2019 and 2018, the Company has accounted for the impact of the new TCJA provisions, as well as any adjustments with respect to the re-measurement of its deferred taxes, as part of its income tax benefit using the currently available regulations and technical guidance on the interpretations of the TCJA. The Company has elected to account for GILTI as a period cost. The Company is not currently subject to the Base Erosion and Anti-Abuse Tax (“BEAT”) or Section 163(j) Interest Limitation. The Company will continue to monitor the forthcoming regulations and additional guidance of the GILTI, FDII, and BEAT provisions under the TCJA, which are complex and subject to continuing regulatory interpretation by the Internal Revenue Service (“IRS”).

(c) For the year ended December 31, 2018, the Company released valuation allowance recorded against deferred tax assets in certain foreign jurisdictions as it had achieved three years of cumulative pre-tax income.
Significant Components of Deferred Tax Assets and Liabilities Significant components of the Company’s deferred tax assets (liabilities) are as follows (in thousands):
 
As of December 31,
 
2019
 
2018
Deferred tax assets:
 
 
 
 Net operating loss carryforwards
$
19,599

 
$
13,347

 Research and development credit carryforwards
13,133

 
7,567

 Lease liability (a)
18,666

 

 Stock-based compensation expense
7,642

 
6,623

 Excess tax basis in intangible assets
3,572

 
12,109

 Accrued bonus
4,065

 
1,049

 Deferred rent (a)

 
529

 Other deferred tax assets
3,944

 
1,858

 Total deferred tax assets
70,621

 
43,082

 Less: valuation allowance
883

 
1,673

 Total net deferred tax asset
69,738

 
41,409

 
 
 
 
 Deferred tax liabilities:
 
 
 
 Excess book basis in intangible assets
(39,500
)
 
(362
)
 Restructuring liability
(29,635
)
 
(33,730
)
 Convertible debt
(22,839
)
 
(7,283
)
 Right-of-use asset (a)
(17,596
)
 

 Depreciation (a)
(10,328
)
 
(6,933
)
 Other deferred tax liabilities
(80
)
 
(92
)
Total deferred tax liabilities
(119,978
)
 
(48,400
)
Net deferred tax liabilities
$
(50,240
)
 
$
(6,991
)

 
(a) As part of the Company’s adoption of ASC 842 beginning in 2019, the Company recorded adjustments to the GAAP basis of certain assets and liabilities and established other assets and liabilities (i.e., right-of-use asset and lease liability). The net adjustment was recorded as a retrospective adjustment to retained earnings. The adoption of ASC 842 does not change the Company’s tax basis in these assets and liabilities. However, as a result of the adoption, an adjustment was recorded to the historic deferred taxes,
through retained earnings, to account for the change in GAAP basis as well as establishing deferred taxes on the newly established right-of-use assets and lease liabilities.

Summary of Tax Credit Carryforwards
As of December 31, 2019, the Company had the following operating loss and tax credit carryforwards available to offset taxable income in future years:
 
December 31, 2019
 
Expiration Period
U.S. Federal net operating loss carryforwards
$
30,403

 
2035-Unlimited
U.S. Federal credit carryforwards
13,054

 
2035-2039
U.S. State net operating loss carryforwards
21,150

 
2027-2039
U.S. State credit carryforwards
184

 
2020-2024
Non-U.S. net operating loss carryforwards
91,440

 
Unlimited

Summary of Operating Loss Carryforwards
As of December 31, 2019, the Company had the following operating loss and tax credit carryforwards available to offset taxable income in future years:
 
December 31, 2019
 
Expiration Period
U.S. Federal net operating loss carryforwards
$
30,403

 
2035-Unlimited
U.S. Federal credit carryforwards
13,054

 
2035-2039
U.S. State net operating loss carryforwards
21,150

 
2027-2039
U.S. State credit carryforwards
184

 
2020-2024
Non-U.S. net operating loss carryforwards
91,440

 
Unlimited

Summary of Valuation Allowance
The following table summarizes the valuation allowance activity for the periods indicated (in thousands):
 
Year Ended  
December 31,
 
2019
 
2018
 
2017
Balance as of the beginning of period
$
1,673

 
$
32,455

 
$
13,839

Additions charged to expense
504

 

 
16,743

Deletions credited to expense
(4
)
 
(28,733
)
 

Currency translation and other balance sheet activity
(1,290
)
 
(2,049
)
 
1,873

Balance as of the end of period
$
883

 
$
1,673

 
$
32,455


Schedule of Unrecognized Tax Benefits Activity
The following table summarizes the unrecognized tax benefit activity for the periods indicated (in thousands):
 
As of December 31,
 
2019
 
2018
 
2017
Balance as of the beginning of period
$
18,819

 
$
17,013

 
$
23,574

Additions based on tax positions related to the current year
1,847

 
921

 
732

Additions for tax positions of prior years
3,620

 
946

 
118

Reductions for tax provisions of prior years
(2,423
)
 
(61
)
 
(7,411
)
Lapse of Statute of Limitation
(184
)
 

 

Additions recorded through goodwill as part of business combination
1,334

 

 

Settlements
(3,080
)
 

 

Balance as of the end of period
$
19,933

 
$
18,819

 
$
17,013